GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review ; volume:14 ; number:1 ; day:2 ; month:2 ; year:2024 ; pages:1-13 ; date:12.2024
Blood cancer journal ; 14, Heft 1 (2.2.2024), 1-13, 12.2024
- Creator
-
Rodriguez-Otero, Paula
Donk, Niels van de
Pillarisetti, Kodandaram
Cornax, Ingrid
Vishwamitra, Deeksha
Gray, Kathleen
Hilder, Brandi
Tolbert, Jaszianne
Renaud, Thomas
Masterson, Tara
Heuck, Christoph
Kane, Colleen
Verona, Raluca
Moreau, Philippe
Bahlis, Nizar
Chari, Ajai
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41408-023-00966-9
- URN
-
urn:nbn:de:101:1-2405102101080.893187132019
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rodriguez-Otero, Paula
- Donk, Niels van de
- Pillarisetti, Kodandaram
- Cornax, Ingrid
- Vishwamitra, Deeksha
- Gray, Kathleen
- Hilder, Brandi
- Tolbert, Jaszianne
- Renaud, Thomas
- Masterson, Tara
- Heuck, Christoph
- Kane, Colleen
- Verona, Raluca
- Moreau, Philippe
- Bahlis, Nizar
- Chari, Ajai
- SpringerLink (Online service)
Other Objects (12)
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
Multiple myeloma
WDR26 and MTF2 are therapeutic targets in multiple myeloma
Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage
Novel immunotherapies in multiple myeloma – chances and challenges
Natural killer cells efficiently target multiple myeloma clonogenic tumor cells
RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation
Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
Imaging of Multiple Myeloma
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
From transplant to novel cellular therapies in multiple myeloma : : european myeloma network guidelines and future perspectives
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
Multiple myeloma
WDR26 and MTF2 are therapeutic targets in multiple myeloma
Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage
Novel immunotherapies in multiple myeloma – chances and challenges
Natural killer cells efficiently target multiple myeloma clonogenic tumor cells
RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation
Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
Imaging of Multiple Myeloma
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
From transplant to novel cellular therapies in multiple myeloma : : european myeloma network guidelines and future perspectives
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
Multiple myeloma
WDR26 and MTF2 are therapeutic targets in multiple myeloma
Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage
Novel immunotherapies in multiple myeloma – chances and challenges
Natural killer cells efficiently target multiple myeloma clonogenic tumor cells
RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation
Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
Imaging of Multiple Myeloma
Proteasome inhibition: the dawn of novel therapies in multiple myeloma
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies